Chapter 7. Biomarkers for Risk Stratification in Patients with Heart Failure

  1. James A. de Lemos MD Associate Professor of Medicine Coronary Care Unit Director
  1. W. H. Wilson Tang MD, FAHA Assistant Professor of Medicine

Published Online: 13 JAN 2009

DOI: 10.1002/9781444300208.ch7

Biomarkers in Heart Disease

Biomarkers in Heart Disease

How to Cite

Tang, W. H. W. (2008) Biomarkers for Risk Stratification in Patients with Heart Failure, in Biomarkers in Heart Disease (ed J. A. de Lemos), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300208.ch7

Editor Information

  1. University of Texas Southwestern Medical Center Dallas, TX, USA

Author Information

  1. Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA

Publication History

  1. Published Online: 13 JAN 2009
  2. Published Print: 18 APR 2008

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman

ISBN Information

Print ISBN: 9781405175715

Online ISBN: 9781444300208



  • risk stratification biomarkers in HF;
  • cardiac-specific biomarkers for risk stratification;
  • natriuretic peptide testing in acute HF;
  • Acute Decompensated Heart Failure National Registry (ADHERE) with B-type natriuretic peptide (BNP);
  • cardiac troponin testing in acute HF;
  • risk stratification noncardiac biomarkers;
  • blood urea nitrogen, creatinine and cystatin C;
  • inflammatory and oxidative stress biomarkers;
  • natriuretic peptide and cardiac troponin testing - holding promise for HF


This chapter contains sections titled:

  • Introduction

  • Current controversies

  • Conclusions

  • Acknowledgments

  • References